NCT00653393View on ClinicalTrials.gov

Bioavailability Study of Tranylcypromine 10mg Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

November 30, 2004

Study Completion Date

December 31, 2004

Conditions
To Determine the Bioavailability of Tranylcypromine
Interventions
DRUG

Tranylcypromine

Tablets, 10 mg, single-dose

DRUG

Parnate

Tablets, 10 mg, single-dose

Trial Locations (1)

33901

SFBC Ft. Myers, Inc, Fort Myers

Sponsors
All Listed Sponsors
collaborator

SFBC Ft. Myers, Inc

INDUSTRY

lead

Par Pharmaceutical, Inc.

INDUSTRY